Literature DB >> 9174188

Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods.

J C Chang1, P R Hsueh, J J Wu, S W Ho, W C Hsieh, K T Luh.   

Abstract

A total of 106 clinical isolates of flavobacteria, including 41 isolates of Flavobacterium meningosepticum, 59 of Flavobacterium indologenes, and 6 of Flavobacterium odoratum were collected from January 1992 to December 1995 from patients in Taiwan. The in vitro activities of antimicrobial agents were determined concomitantly by the standard agar dilution and disk diffusion methods. More than 90% of the flavobacterial isolates were resistant to cephalothin, cefotaxime, ceftriaxone, moxalactam, aztreonam, imipenem, aminoglycosides, erythromycin, and glycopeptides. The majority of F. meningosepticum isolates were susceptible to piperacillin and to minocycline but resistant to ceftazidime, with MICs at which 90% of the isolates are inhibited being 8, 4, and > 128 microg/ml, respectively. Approximately half of the F. indologenes isolates were susceptible to piperacillin, cefoperazone, ceftazidime, and minocycline, with MICs at which 50% of the isolates are inhibited being 4, 16, 8, and 4 microg/ml, respectively. The majority of F. odoratum isolates were resistant to all the antimicrobial agents tested except minocycline, to which five of six isolates were susceptible. With least-squares regression analysis and error rate-bounded analysis methods, the following resistant and susceptible zone diameter breakpoints were established: < or = 12 and > or = 17 mm, respectively, for piperacillin against F. meningosepticum and F. indologenes; < or = 13 and > or = 18 mm, respectively, for ceftazidime against F. meningosepticum and F. indologenes, < or = 17 and > or = 21 mm, respectively, for ofloxacin against F. indologenes; < or = 16 and > or = 20 mm, respectively, for ciprofloxacin against F. meningosepticum. Valid breakpoints for the disk diffusion method could not be established for cefoperazone and ofloxacin against F. meningosepticum and for minocycline against F. meningosepticum and F. indologenes due to a poor correlation coefficient for the regression line or for cefoperazone and ciprofloxacin against F. indologenes due to the presence of remarkable error rates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174188      PMCID: PMC163904          DOI: 10.1128/AAC.41.6.1301

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  30 in total

1.  Epidemic meningitis of the newborn caused by flavobacteria. II. Clinical manifestations and treatment.

Authors:  R M GEORGE; C P COCHRAN; W E WHEELER
Journal:  Am J Dis Child       Date:  1961-03

Review 2.  Fatal pneumonia caused by Flavobacterium meningosepticum.

Authors:  A Y Tam; R W Yung; K H Fu
Journal:  Pediatr Infect Dis J       Date:  1989-04       Impact factor: 2.129

3.  Flavobacterium meningosepticum keratitis successfully treated with topical trimethoprim-sulfamethoxazole.

Authors:  F A Bucci; E J Holland
Journal:  Am J Ophthalmol       Date:  1991-01-15       Impact factor: 5.258

4.  Subacute bacterial endocarditis due to Flavobacterium meningosepticum.

Authors:  S Werthamer; M Weiner
Journal:  Am J Clin Pathol       Date:  1972-03       Impact factor: 2.493

5.  Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections.

Authors:  Y Siegman-Igra; D Schwartz; G Soferman; N Konforti
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

6.  Bacteremic necrotizing fasciitis due to Flavobacterium odoratum.

Authors:  P R Hsueh; J J Wu; T R Hsiue; W C Hsieh
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

7.  Indwelling arterial catheters as a source of nosocomial bacteremia. An outbreak caused by Flavobacterium Species.

Authors:  W E Stamm; J J Colella; R L Anderson; R E Dixon
Journal:  N Engl J Med       Date:  1975-05-22       Impact factor: 91.245

8.  Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa.

Authors:  B E Scully; H C Neu
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

9.  Comparative in-vitro activity of ciprofloxacin against non-fermenters.

Authors:  M O Husson; D Izard; L Bouillet; H Leclerc
Journal:  J Antimicrob Chemother       Date:  1985-04       Impact factor: 5.790

10.  Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan.

Authors:  P R Hsueh; H M Chen; A H Huang; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

View more
  19 in total

1.  Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningosepticum in nonneonatal patients.

Authors:  Pen-Yi Lin; Chishih Chu; Lin-Hui Su; Chung-Tsui Huang; Wen-Ya Chang; Cheng-Hsun Chiu
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  MYROIDES INFECTION IN A BABOON AFTER PROLONGED PIG KIDNEY GRAFT SURVIVAL.

Authors:  Hong Liu; Hayato Iwase; Martin Wijkstrom; Jagjit Singh; Edwin Klein; Robert Wagner; Abhinav Humar; William Pasculle; David K C Cooper
Journal:  Transplant Direct       Date:  2015-05

3.  Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome.

Authors:  P R Hsueh; L J Teng; P C Yang; S W Ho; K T Luh
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

4.  Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum.

Authors:  S Bellais; L Poirel; T Naas; D Girlich; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

5.  Septic shock, pneumonia, and soft tissue infection due to Myroides odoratimimus: report of a case and review of Myroides infections.

Authors:  P Benedetti; M Rassu; G Pavan; A Sefton; G Pellizzer
Journal:  Infection       Date:  2011-01-19       Impact factor: 3.553

6.  Catheter-related Chryseobacterium meningosepticum bacteraemia in a haemodialysis patient.

Authors:  Min-Hua Tseng; Liang-Kuang Diang; Yi-Chen Su; Shih-Hua Lin
Journal:  NDT Plus       Date:  2009-10

7.  Elizabethkingia meningoseptica: Emerging nosocomial pathogen in bedside hemodialysis patients.

Authors:  M S Ratnamani; Ratna Rao
Journal:  Indian J Crit Care Med       Date:  2013-09

8.  Chryseobacterium indologenes peritonitis in a patient with malignant ascites.

Authors:  Yung-Chih Wang; Kuo-Ming Yeh; Sheng-Kang Chiu; Shih-Ta Shang; Li-Ping Kan; Ching-Mei Yu; Jung-Chung Lin
Journal:  Int Med Case Rep J       Date:  2011-01-20

9.  Current status of antimicrobial resistance in Taiwan.

Authors:  Po-Ren Hsueh; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

10.  Antibacterial activities of multi drug resistant Myroides odoratimimus bacteria isolated from adult flesh flies (Diptera: sarcophagidae) are independent of metallo beta-lactamase gene.

Authors:  M S Dharne; A K Gupta; A Y Rangrez; H V Ghate; M S Patole; Y S Shouche
Journal:  Braz J Microbiol       Date:  2008-06-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.